When to use drugs to help sleep

Archives of Disease in Childhood

Volumn 93, Issue 11, 2008, Pages 976-981

  Gringras, Paul ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE; CHLORAL HYDRATE; CLONAZEPAM; CLONIDINE; HERBACEOUS AGENT; HYPNOTIC AGENT; MELATONIN; PLACEBO; TRICLOFOS; VALERIAN; ZALEPLON; ZOLPIDEM; ZOPICLONE;

AMNESIA; ARRHYTHMOGENESIS; ATAXIA; BEHAVIOR DISORDER; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; HALLUCINATION; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; HYPERSOMNIA; INSOMNIA; INTERVENTION STUDY; LOW DRUG DOSE; NARCOLEPSY; NIGHTMARE; PARASOMNIA; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SLEEP DISORDER;

CHILD; HUMANS; HYPNOTICS AND SEDATIVES; MELATONIN; NARCOLEPSY; PARASOMNIAS; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 55349146622     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.128728     Document Type: Review

References (45)

1. Hill CM, Hogan AM, Karmiloff-Smith A. To sleep, perchance to enrich learning? Arch Dis Child 2007;92:637-43.
2. Chen X, Beydoun MA, Wang Y. Is sleep duration associated with childhood obesity? A systematic review and meta-analysis. Obesity 2008;16:265-74.
3. Gringras P, Jaffe A, Sheldon S. ADHD and sleep problems. In: Taylor E, ed. Children with hyperactivity: understanding and managing their problems. Cambridge: MacKeith Press, 2007:160-9.
4. Stores G, Crawford C. Medical student education in sleep and its disorders. J R Coll Physicians Lond 1998;32:149-53.
5. American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. 2nd edn. Westchester, IL: American Academy of Sleep Medicine, 2005.
6. Jenni OG. Sleep onset insomnia during childhood or poor fit between biology and culture: comment on van der Heijden et al. 'Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia'. J Sleep Res 2005;14:195-7
7. Ivanenko A, Barnes ME, Crabtree VM, et al. Psychiatric symptoms in children with insomnia referred to a pediatric sleep medicine center. Sleep Med 2004;5:253-9.
8. Morgenthaler TI, Owens J, Alessi C, et al. Practice parametets for behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep 2006;29:1277-81.
9. Waldron DL, Bramble D, Gringras P. Melatonin: prescribing practices and adverse events. Arch Dis Child 2005;90:1206-7.
10. Smits MG, Nagtegaal EE, van der Heijden J, et al. Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol 2001;16:86-92.
11. Weiss MD, Wasdell MB, Bomben MM, et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 2006;45:512-19.
12. Van der Heijden KB, Smits MG, Van Someren JW, et al. Effect of melatonin on sleep, behavior and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry 2007;46:233-41.
13. Phillips L, Appleton R. Systematic review of melatonin in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol 2004;46:771-5.
14. Sajith SG, Clarke D. Melatonin and sleep disorders associated with intellectual disability: a clinical review. J Intellect Disabil Res 2007;51:2-13.
15. Wasdell MB, Jan JE, Bomben MM, et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008;44:57-64.
16. UKCRN. MENDS: The use of melatonin in children with neurodevelopmental disorders and impaired sleep: an RCT. Principal investigators: Dr R Appleton and Dr P Gringras. EUDRACT 2006-004025-28. UKCRN ID 2258. See http://pfsearch.ukcrn.org. uk/StudyDetail.aspx?TopicID=4&StudyID= 2258 (accessed 20 August 2008)
17. Carr M, Wasdell M, Hamilton D, et al. Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders. J Pineal Res 2007;43:351-9.
18. France KG, Blampied NM, Wilkinson P. A multiple-baseline, double-blind evaluation of the effects of trimeprazine tartrate on infant sleep disturbance. Exp Clin Psychopharmacol 1999;7:502-13.
19. Merenstein D, Diener-West M, Halbower AC, et al. The trial of infant response to diphenhydramine. Arch Pediatr Adolesc Med 2006;160:707-12.
20. Schnoes CJ, Kuhn BR, Workman EF, et al. Pediatric prescribing practices for clonidine and other pharmacologic agents for children with sleep disturbance. Clin Pediatr 2006;45:229-38.
21. Dündar Y, Dodd S, Strobl J, et al. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 2004;19:305-22.
22. Blumer JL, Reed MD, Steinberg F, et al. Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties. Clin Pharmacol Ther 2008;83:551-8.
23. ClinicalTrials.gov. Efficacy, safety, and tolerability of Ambien (zolpidem) in the treatment of children ages 6 to 17 with attention deficit hyperactivity disorder (ADHD)-associated insomnia. ClinicalTrials.gov Identifier: NCT00318448. See http://clinicaltrials.gov/ct2/show/NCT00318448? intr=%22Zolpidem%22&rank=14 (accessed 20 August 2008).
24. Wheatley D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 2005;19:414-21.
25. Francisa AJP, Dempster RJW. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomised trial. Phytomedicine 2002;9:273-9.
26. Archer SN, Robilliard DL, Skene DJ, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003;26:413-15.
27. Czeisler CA, Richardson GS, Coleman RM, et al. Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep 1981;4:1-21.
28. Nagtegaal JE, Kerkhof GA, Smits MG, et al. Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res 1998;7:135-43.
29. Revell VL, Burgess HJ, Gazda CJ, et al. Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light. J Clin Endocrinol Metab 2006;91:54-9.
30. Lask B. Novel and non-toxic treatment for night terrors. BMJ 1988;297:592.
31. Etzioni T, Katz N, Hering E, et al. Controlled sleep restriction for rhythmic movement disorder. J Pediatr 2005;147:393-5.
32. Schenck CH, Bundlie SR, Ettinger MG, et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986;9:293-308.
33. Rajaram SS, Walters AS, England SJ, et al. Some children with growing pains may actually have restless legs syndrome. Sleep 2004;27:767-73.
34. Cortese S, Konofal E, Lecendreux M, et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 2005;28:1007-13.
35. Martinez S, Guilleminault C. Periodic leg movements in prepubertal children with sleep disturbance. Dev Med Child Neurol 2004;46:765-70.
36. Simakajornboon N, Gozal D, Vlasic V, et al. Periodic limb movements in sleep and iron status in children. Sleep 2003;26:735-8.
37. Vignatelli L, Billiard M, Clarenbach P, et al. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol 2006;13:1049-65.
38. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838-44.
39. Goldbart AD, Goldman JL, Veling MC, et al. Leukotriene modifier therapy for mild sleep-disordered breathing in children [see comment]. Am J Respir Crit Care Med 2005;172:364-70.
40. Challamel MJ, Mazzola ME, Nevsimalova S, et al. Narcolepsy in children. Sleep 1994;17:S17-S20.
41. Allsopp MR, Zaiwalla Z. Narcolepsy. Arch Dis Child 1992;67:302-6.
42. Billiarda C, Bassettib Y, Dauvillier SC, et al. EFNS guidelines on management of narcolepsy. Eur J Neurol 2006;13:1035- 48.
43. U.S. Xyrem Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med 2004;5:119-23.
44. Dauvilliers Y, Carlander B, Rivier F, et al. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 2004;56:905-8.
45. Arnulf I, Zeitzer JM, File J, et al. Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain 2005;128:2763-76.